Health care has been a bad investment. Lots of money into a system that isn't improving our health or the patient experience. Silicon Valley-backed startups intend to change that.
CNBC's Herb Greenberg has the story on a big battle brewing over where prescriptions are filled and how much you are going to pay, with Mark Merritt, PCMA president & CEO, and David Balto, antitrust attorney.
Objections to Express Scripts' $29 billion plan to buy rival pharmacy benefits manager Medco Health are growing, with CNBC's Bertha Coombs.
Insight on what creates value in major mergers, with Maria Gabelli, GAMCO Investors and CNBC's David Faber.
Discussing whether the deal between Express Scripts and Medco will give a real leg up in pricing and competition, with Les Funtleyder, Miller Tabak portfolio manager.
Insight on what the huge deal in the healthcare sector will mean for the industry going forward, with Eugene Goldenberg,BB&T Capital Markets.
A look at what the deal between Express Scripts and Medco Health means for the already changing healthcare industry, with Steven Halper, Stifel Nicolaus managing director.
CNBC's David Faber has the details on the deal between Express Script and Medco.